Exabis Library
Welcome to the e-CCO Library!
P279: Vedolizumab is safe for use in pregnant patients with IBD; report of our preliminary data
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P280 Sodium picosulfate low-volume and split-dosed bowel preparation facilitates endoscopic monitoring of patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P280: Endoscopic training leads to a significant increase in agreement of endoscopic scoring for inflammatory bowel disease: results of the IGIBDEndo educational project
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P280: Introduction of subcutaneous infliximab CT-P13 and vedolizumab in daily clinical practice: outstanding questions demonstrate the need for post-marketing studies
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P280: Prediction factors for low bone mineral density in children with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P280: Prognosis of patients with Crohns Disease in transmural remission with gastrointestinal ultrasound
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P280: Quality of life in military patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P280: Reducing the overprescribing of oral corticosteroids in IBD using a steroid assessment tool
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P280: Therapeutic drug monitoring of infliximab and adalimumab for detection of patients at risk of loss of response in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P281 A serum biomarker panel can accurately identify the presence of mucosal ulcers in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P281: Combined clinical and biological response (concomitant CRP and faecal calprotectin reductions) in induction and maintenance from the phase 3 ustekinumab Crohn’s disease studies
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P281: Conversion of the ileal pouch-anal anastomosis to a continent ileostomy – outcome and patient satisfaction
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P281: Endoscopic healing assessed by advanced optical enhancement techniques combined with faecal calprotectin (FCP) can accurately assess histological healing in ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P281: Evaluation of trough level and disease activity after switch from adalimumab originator to biosimilar in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P281: Factors at diagnosis associated with disabling disease course in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P281: One simple question is sufficient for measuring medication adherence in inflammatory bowel disease patients using self-report
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P281: TELEIBD: A telematic fast-track pathway for patients with high suspicion of Inflammatory Bowel Disease in primary care.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P282 Early disease acceleration in patients with newly diagnosed Crohn’s disease in India and Israel: Insights from an East-West inception cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P282: Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P282: Despite surveillance and increased use of biologics and immunosuppressives colorectal cancer detection in IBD patients remains unchanged over the past ten years
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM